US Stock MarketDetailed Quotes

SLP Simulations Plus

Watchlist
  • 36.360
  • +1.100+3.12%
Trading Apr 24 12:19 ET
731.24MMarket Cap101.00P/E (TTM)

About Simulations Plus Company

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.

Company Profile

SymbolSLP
Company NameSimulations Plus
Listing DateJun 18, 1997
Issue Price5.00
Founded1996
CEOMr. Shawn O’Connor
MarketNASDAQ
Employees247
Fiscal Year Ends08-31
Address800 Park Offices Drive,Suite 401,Research Triangle Park
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-661-723-7723

Company Executives

  • Name
  • Position
  • Salary
  • Shawn O’Connor
  • Chief Executive Officer
  • 1.66M
  • William Frederick
  • Chief Operating Officer,Chief Financial Officer and Principal Accounting Officer
  • 1.01M
  • Daniel Szot
  • Chief Revenue Officer
  • 895.07K
  • Jill Fiedler-Kelly, M.S.
  • Co-President, Clinical Pharmacology and Pharmacometric Services
  • --
  • Jenna Rouse
  • President, Adaptive Learning and Insights
  • --
  • Steven Chang
  • President, Quantitative Systems Pharmacology Solutions
  • 656.41K
  • Murry Alper
  • President, Medical Communications
  • --
  • John A. DiBella
  • President, PBPK, Regulatory Strategies and Cheminformatics Solutions
  • 661.62K
  • Dr. Jonathan Chauvin
  • Co-President, Clinical Pharmacology and Pharmacometric Services
  • --
  • Dr. Daniel Weiner
  • Chairman of the Board
  • 210.07K
  • Sharlene Evans
  • Independent Director
  • 187.57K
  • Dr. Walter S. Woltosz
  • Independent Director
  • 200.07K
  • Dr. Lisa LaVange
  • Independent Director
  • 190.07K
  • Dr. John K. Paglia, C.F.A.,C.P.A.,PhD
  • Independent Director
  • 200.07K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.